Christian Weyer, M.D., M.A.S
2020 - Intercept Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $170,804 |
|---|---|
| Option Awards | $453,467 |
| Salary | $486,731 |
| Stock Awards | $925,704 |
| Other | $21,910 |
| Total | $2,058,616 |
MAS received $925.7K in stock awards, accounting for 45% of the total pay in 2020.
MAS also received $170.8K in non-equity incentive plan, $453.5K in option awards, $486.7K in salary and $21.9K in other compensation.
Rankings
In 2020, Christian Weyer, M.D., M.A.S' compensation ranked 5,378th out of 13,090 executives tracked by ExecPay. In other words, MAS earned more than 58.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,378 out of 13,090 | 59th |
Division Manufacturing | 2,215 out of 5,618 | 61st |
Major group Chemicals And Allied Products | 886 out of 2,251 | 61st |
Industry group Drugs | 764 out of 1,951 | 61st |
Industry Pharmaceutical Preparations | 572 out of 1,456 | 61st |
Pay ratio
| Christian Weyer, M.D., M.A.S' Pay | $2,058,616 |
|---|---|
| Median Employee's Pay | $267,493 |
| Pay Ratio | 8to 1 |
In 2020, the annual total compensation of Christian Weyer, M.D., M.A.S was $2,058,616.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $267,493.
The ratio of Christian Weyer, M.D., M.A.S' pay to the pay of median employee was therefore 8 to one.
MAS' colleagues
We found six more compensation records of executives who worked with Christian Weyer, M.D., M.A.S at Intercept Pharmaceuticals in 2020.
2020
Mark Pruzanski
Intercept Pharmaceuticals
Chief Executive Officer
2020
Jerome Durso
Intercept Pharmaceuticals
Chief Operating Officer
2020
Sandip Kapadia
Intercept Pharmaceuticals
Chief Financial Officer
2020
Richard Kim
Intercept Pharmaceuticals
Former President, U.S. Commercial & Strategic Marketing
2020
Lisa Bright
Intercept Pharmaceuticals
Former President, International
2020
Ryan Sullivan
Intercept Pharmaceuticals